For Biotech Takeovers, Timing is Key:
BOSTON (TheStreet) --
Yet another Vivus takeover rumor circulating through the market Tuesday got me thinking: When do most biotech and drug takeovers happen? Is it possible that Vivus -- which will hear from FDA in just 13 days about the approval decision for its weight-loss drug Qnexa -- could be right now in secret negotiations with a Big Pharma suitor?
Not likely if history is any guide. Biotech and small drug companies are rarely acquired immediately before or after a drug approval or even during the initial phase of a new drug launch.
An acquisition of Vivus now, with FDA's approval decision on Qnexa looming on April 17, would be an exception to the biotech takeover rule. The same likely applies to Arena Pharmaceuticals and Discovery Labs, both of which are in a similar situation as Vivus and have been the subject of recent takeover speculation.
...
Click to view a price quote on VVUS.
Click to research the Drugs industry.
BOSTON (TheStreet) --
Yet another Vivus takeover rumor circulating through the market Tuesday got me thinking: When do most biotech and drug takeovers happen? Is it possible that Vivus -- which will hear from FDA in just 13 days about the approval decision for its weight-loss drug Qnexa -- could be right now in secret negotiations with a Big Pharma suitor?
Not likely if history is any guide. Biotech and small drug companies are rarely acquired immediately before or after a drug approval or even during the initial phase of a new drug launch.
An acquisition of Vivus now, with FDA's approval decision on Qnexa looming on April 17, would be an exception to the biotech takeover rule. The same likely applies to Arena Pharmaceuticals and Discovery Labs, both of which are in a similar situation as Vivus and have been the subject of recent takeover speculation.
...
Click to view a price quote on VVUS.
Click to research the Drugs industry.
Comments